Centre Henri Becquerel

Rouen, Seine-Maritime 76038

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Lymphoma, Non-Hodgkin, Relapsed/Refractory Peripheral T-cell Lymphoma

Studies at this site

• A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) — Stopped early
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma — Stopped early